|
3.1. In
your opinion which one is the best Intra-operative staging system for patients
affected by peritoneal carcinomatosis?
(just one alternative allowed)
|
French system ([19])
First round: 9,68 % - Second round: 6,25 % |
|
Japanese system ([20])
First round: 0 % - Second round: 0 % |
|
Peritoneal cancer Index ([21])
First round: 83,87 % - Second round: 87,50 % |
|
Dutch Simplified Peritoneal Cancer Index ([22])
First round: 6,45 % - Second round: 6,25 % |
|
TNM system.([23])
First round: 0 % - Second round: 0 % |
| [19] Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B, Bienvenu J, Burgard G, Guibert B, Banssillon V, et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology. 1994 Apr;41(2):124-9 |
| [20] Japanese Research Society for Gastric Cancer (1981): Jpn J Surg, 11:127-139, 1981. |
[21] Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.
In Peritoneal carcinomatosis: principles of management. Edited by: Sugarbaker PH. Boston: Kluwer Academic publishers; 1996:359-374.  |
| [22] Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoetmulder FA: Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001, 37:979-984. |
| [23] http://www.uicc.org. Last access 7/2006 |
-----------------------------------------------------------------------------------------------
|
